Myriad — Under The Microscope

Law360, New York (August 17, 2012, 4:55 PM EDT) -- On Aug. 16, 2012, the U.S. Court of Appeals for the Federal Circuit decided Association for Molecular Pathology v. Myriad Genetics Inc., No. 2010-1406, on remand from the U.S. Supreme Court to consider the impact of Mayo Collaborative Services v. Prometheus Inc., 566 U.S. ___, 132 S. Ct. 1289 (2012). As explained below, the Federal Circuit’s ruling largely aligns with the same panel’s previously vacated July 29, 2011, decision.

On the threshold issue of jurisdiction, the court reaffirmed the district court’s decision to exercise declaratory judgment...
To view the full article, register now.